Viewing Study NCT04985266


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-02-05 @ 10:59 AM
Study NCT ID: NCT04985266
Status: RECRUITING
Last Update Posted: 2024-12-05
First Post: 2021-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Sponsor: Royal Marsden NHS Foundation Trust
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ER+ Breast Cancer View
None HER2-negative Breast Cancer View
Keywords: